MedTrace Logo

The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata

NCT00941889 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 32

Last updated 2016-07-25

Study results available
· View outcomes & findings →

Summary

The primary objective of this pilot study is to evaluate the effect of the HPV vaccine Gardasil on anal condylomata recurrence and persistence rates in HIV positive patients.

Conditions

  • HIV Positive
  • Anal Condylomata
  • Anal Warts
  • HIV Infections

Interventions

DRUG

Saline

0.5 ml

DRUG

Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine

0.5mL intramuscular injection of Gardasil (quadrivalent HPV vaccine) in their upper extremity initially and again at two months and six months after enrollment.

Sponsors & Collaborators

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Steven R Hunt, MD · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-07-31
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00941889 on ClinicalTrials.gov